Detalles de la búsqueda
1.
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 24, 2024 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321542
2.
Multi-Institutional Study of Pathologist Reading of the Programmed Cell Death Ligand-1 Combined Positive Score Immunohistochemistry Assay for Gastric or Gastroesophageal Junction Cancer.
Mod Pathol
; 36(5): 100128, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889057
3.
Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer.
Lab Invest
; 98(8): 1076-1083, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29858579
4.
Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Breast Cancer Res Treat
; 172(2): 327-338, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120700
5.
High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence.
Lab Invest
; 97(12): 1521-1526, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28892092
6.
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.
Breast Cancer Res
; 17: 41, 2015 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886996
7.
Prolonged Response to Trastuzumab in a Patient With HER2-Nonamplified Breast Cancer With Elevated HER2 Dimerization Harboring an ERBB2 S310F Mutation.
J Natl Compr Canc Netw
; 13(9): 1066-70, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26358791
8.
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 141(1): 43-53, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959396
9.
Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data.
Antimicrob Agents Chemother
; 56(11): 5938-45, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22964257
10.
Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.
Oncologist
; 17(1): 26-35, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234627
11.
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC.
J Thorac Oncol
; 17(9): 1078-1085, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764237
12.
Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.
Am J Clin Pathol
; 156(5): 766-776, 2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34050358
13.
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment.
Cancers (Basel)
; 13(18)2021 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34572945
14.
Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma Samples.
Anticancer Res
; 40(11): 6229-6236, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33109560
15.
Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma.
J Immunother Cancer
; 7(1): 254, 2019 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533832
16.
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer.
NPJ Breast Cancer
; 5: 28, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31482108
17.
p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial.
Clin Cancer Res
; 24(13): 3046-3052, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29535130
18.
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).
Clin Cancer Res
; 24(13): 3053-3058, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29530935
19.
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity.
AIDS
; 20(16): 2123-5, 2006 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-17053362
20.
Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.
Clin Infect Dis
; 43(10): 1329-36, 2006 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17051502